Document Detail


Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia.
MedLine Citation:
PMID:  10411808     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Maternal serum inhibin A concentration is elevated in established preeclampsia. The aim of this study was to investigate whether this relationship antedates the appearance of the classic signs of preeclampsia. STUDY DESIGN: A retrospective analysis was performed on trisomy 21 screening data from 685 women at between 15 and 19 weeks' gestation. The main outcome measures were preeclampsia and small for gestational age (<5th percentile) infants. RESULTS: Preeclampsia developed in 35 women (5.5%). Women with inhibin A concentration >2.0 multiples of the median were significantly more likely to acquire preeclampsia (P <.00001) and to be delivered of a small for gestational age infant (<5th percentile, P <.00001) than were women with inhibin A concentration </=2.0 multiples of the median. The odds ratios were 9.4 (95% confidence interval 4.6-19.3) for development of preeclampsia and 18.2 (95% confidence interval 6. 0-54.8) for preeclampsia necessitating delivery at <37 weeks' gestation. The association remained statistically significant for nulliparous women. CONCLUSION: Elevated maternal inhibin A concentration in the second trimester was strongly associated with a subsequent risk of preeclampsia. The potential role of second trimester inhibin A measurement in a screening strategy for preeclampsia needs to be investigated further.
Authors:
J Aquilina; A Barnett; O Thompson; K Harrington
Related Documents :
18501408 - Increased thrombin generation in women with a history of preeclampsia.
11679788 - Higher risk of pre-eclampsia after change of partner. an effect of longer interpregnanc...
18796628 - Etiologic heterogeneity among non-hodgkin lymphoma subtypes.
22239868 - Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabete...
23630108 - Parity and body mass index in u.s. women: a prospective 25-year study.
20352298 - Short-term weight change and fluctuation as risk factors for type 2 diabetes in finnish...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  181     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-08-19     Completed Date:  1999-08-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  131-6     Citation Subset:  AIM; IM    
Affiliation:
Homerton Hospital National Health Service Trust and St Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary & Westfield College, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood*
Female
Humans
Inhibins / blood*
Odds Ratio
Pre-Eclampsia / blood*,  diagnosis*
Predictive Value of Tests
Pregnancy
Pregnancy Trimester, Second
Prenatal Diagnosis*
Retrospective Studies
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Biological Markers; 57285-09-3/Inhibins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate re...
Next Document:  The location of chronic pregnancy hypertension on the vasoconstriction-volume spectrum: working hypo...